FIELD: chemistry.
SUBSTANCE: invention relates to novel salt forms of a base, where the base is (2-pyrrolidin-1-yl-ethyl)-amide 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylc acid, and where the salt form is selected from a group consisting of citric and phosphate salts, and to their solvates and polymorphs. The invention also relates to a polymorph (form 1) of a phosphate salt in claim 2, to a pharmaceutical composition, to a method of modifying catalytic activity of protein kinase, to a method of preventing or treating protein kinase related disorders in the body, to a method of obtaining crystals of the phosphate salt of the base in claim 1, to a method of obtaining polymorphs of the phosphate salt in claim 2, to a method of obtaining crystals of the citric salt of the base in claim 1, as well as to use of the phosphate salt in claim 2 and citric salt in claim 5.
EFFECT: obtaining new biologically active compounds which modulate protein kinase activity.
17 cl, 8 ex, 8 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
POLYMORPHS OF PYRROL-SUBSTITUTED 2-INDOLINONE PROTEINKINASE INHIBITORS | 2004 |
|
RU2335502C2 |
PURIFIED PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS OF OBTAINING AND APPLICATION THEREOF | 2010 |
|
RU2556205C2 |
SALT FORM OF HUMAN HISTONE METHYLTRANSERASE EZH2 INHIBITOR | 2013 |
|
RU2658911C2 |
SOLID FORMS OF THE COMPOUND MODULATING THE KINASES | 2016 |
|
RU2730506C2 |
3-[1,2,3,6-TETRAHYDROPYRIDIN-2-YL]PYRIDINE GLUTARATE OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF | 2019 |
|
RU2823979C2 |
CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY AND THE USE THEREOF | 2017 |
|
RU2744264C2 |
COMPOSITIONS AND METHODS WHICH CAN BE USED FOR TREATING PROLIFERATIVE DISEASES | 2015 |
|
RU2711500C2 |
NOVEL HYDROSULPHATE SALT | 2006 |
|
RU2418790C2 |
POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE | 2005 |
|
RU2355691C2 |
DIARYLTHIOHYDANTOIN COMPOUND CRYSTAL | 2020 |
|
RU2810214C2 |
Authors
Dates
2010-09-20—Published
2006-09-08—Filed